|
4.2.2019 |
EN |
Official Journal of the European Union |
C 44/46 |
Judgment of the General Court of 22 November 2018 — Endoceutics v EUIPO — Merck (FEMIVIA)
(Case T-59/18) (1)
((EU trade mark - Opposition proceedings - Application for EU word mark FEMIVIA - Earlier EU word mark FEMIBION INTIMA - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001))
(2019/C 44/58)
Language of the case: English
Parties
Applicant: Endoceutics, Inc. (Quebec, Canada) (represented by: M. Wahlin, lawyer)
Defendant: European Union Intellectual Property Office (represented by: A. Lukošiūtė, acting as Agent)
Other party to the proceedings before the Board of Appeal of EUIPO: Merck KGaA (Darmstadt, Germany)
Re:
Action brought against the decision of the Second Board of Appeal of EUIPO of 27 November 2017 (Case R 280/2017-2), relating to opposition proceedings between Merck and Endoceutics.
Operative part of the judgment
The Court:
|
1. |
Dismisses the action; |
|
2. |
Orders Endoceutics, Inc. to pay the costs. |